comprehensive -WSS

comprehensive

author：knowledge 2025-08-26 23:44:45 - browse：8546

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： A Q&A with the global head of Boehringer Ingelheim's innovation unit

focus

explore

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

Surgery pushed Ben Carson to fame

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Devoted Health’s losses in Medicare Advantage persist

Readout LOUD: Venture capital, Gilead, and more M&A

Histogen: Failed biotech offers rare public look inside

focus

comprehensive

focus

Alkermes shareholders re

3 questions for the future of Biden's cancer moonshot

Virginia high school admissions case could be legal follow

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

As demand for Covid shots wanes, Moderna seeks its next success

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Drug repurposing or repositioning? The language matters

Physician executives need more than on

DIEP, the 'gold standard' of breast reconstruction, is under threat

AI gets buy

leisure time

Global cancer cases to surge 77% by 2050, WHO report says

3 questions for the future of Biden's cancer moonshot

Chemotherapy drug shortage eases slightly but still widespread

Chemotherapy drug shortage eases slightly but still widespread

Why age limits for politicians are a terrible idea

Johnson & Johnson sued for allegedly overpaying for workers' drugs

explore

explore

focus

hotspot